Advances in cholangiocyte immunobiology

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 303, Issue 10, 2012, Pages

  Syal, Gaurav ^a   Fausther, Michel ^a   Dranoff, Jonathan A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Defensins; Interferon ; Interleukin 6; Interleukin 8; Monocyte chemoattractant protein 1; Mx proteins; Toll like receptor; Trefoil factors; Tumor necrosis factor a

Indexed keywords

FAS LIGAND; IMMUNOGLOBULIN A; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ARTICLE; BILE DUCT ATRESIA; BILE DUCT DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; CHOLANGIOCYTE; CYTOKINE RELEASE; DOWNSTREAM PROCESSING; EPITHELIUM CELL; FIBROBLAST; GRAFT VERSUS HOST REACTION; HEPATOBILIARY SYSTEM; HISTOCOMPATIBILITY COMPLEX; HLA SYSTEM; HUMAN; IMMUNOBIOLOGY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIVER; LIVER FIBROSIS; LIVER GRAFT REJECTION; MYOFIBROBLAST; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; STELLATE CELL; T LYMPHOCYTE; TH17 CELL;

BETA-DEFENSINS; BILE; BILE DUCTS; BILIARY TRACT; BILIARY TRACT DISEASES; CELL ADHESION MOLECULES; CYTOKINES; EPITHELIUM; GTP-BINDING PROTEINS; HLA-DR ALPHA-CHAINS; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN A; LIVER CIRRHOSIS; TOLL-LIKE RECEPTORS;

EID: 84869161621     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00227.2012     Document Type: Article

References (122)

1. Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW. Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 39: 136-140, 1996.
2. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949, 2007.
3. Al-Masri AN, Flemming P, Rodeck B, Melter M, Leonhardt J, Petersen C. Expression of the interferon-induced Mx proteins in biliary atresia. J Pediatr Surg 41: 1139-1143, 2006.
4. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 34: 1245-1249, 1993.
5. Barrett KE, Ganong WF. Ganong's Review of Medical Physiology. New York: McGraw-Hill Medical, 2010.
6. Beuers U. Crosstalk of liver, bile ducts and the gut. Clin Rev Allergy Immunol 36: 1-3, 2009.
7. Bour ES, Ward LK, Cornman GA, Isom HC. Tumor necrosis factoralpha-induced apoptosis in hepatocytes in long-term culture. Am J Pathol 148: 485-495, 1996.
8. Broome U, Scheynius A, Hultcrantz R. Induced expression of heatshock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 18: 298-303, 1993.
9. Butte MJ, Pena-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. Interaction of human PD-L1 and B7-1. Mol Immunol 45: 3567-3572, 2008.
10. Chen XM, O'Hara SP, LaRusso NF. The immunobiology of cholangiocytes. Immunol Cell Biol 86: 497-505, 2008.
11. Chen XM, O'Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, Limper AH, LaRusso NF. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 175: 7447-7456, 2005.
12. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 282: 28929-28938, 2007.
13. Chuang YH, Lan RY, Gershwin ME. The immunopathology of human biliary cell epithelium. Semin Immunopathol 31: 323-331, 2009.
14. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells 12: 440-455, 1994.
15. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 29: 550-558, 1998.
16. Delacroix DL, Furtado-Barreira G, de Hemptinne B, Goudswaard J, Dive C, Vaerman JP. The liver in the IgA secretory immune system. Dogs, but not rats and rabbits, are suitable models for human studies. Hepatology 3: 980-988, 1983.
17. Demetris AJ, Specht S, Nozaki I, Lunz JG, 3rd Stolz DB, Murase N, Wu T. Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelialmesenchymal transition (EMT) in cholangiocytes. J Hepatol 48: 276-288, 2008.
18. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, Sevigny J. The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/ CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36: 1135-1144, 2002.
19. Dranoff JA, Masyuk AI, Kruglov EA, LaRusso NF, Nathanson MH. Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am J Physiol Gastrointest Liver Physiol 281: G1059-G1067, 2001
20. Dranoff JA, Wells RG. Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51: 1438-1444, 2010.
21. Ezure T, Sakamoto T, Tsuji H, Lunz JG, 3rd Murase N, Fung JJ, Demetris AJ. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 156: 1627-1639, 2000.
22. Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C, Strazzabosco M. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 141: e1491-e1508, 2011.
23. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008.
24. Ge X, Uzunel M, Ericzon BG, Sumitran-Holgersson S. Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis? Liver Transpl 11: 911-921, 2005.
25. Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van De Putte P, Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small prolinerich proteins. Genomics 16: 630-637, 1993.
26. Goldman IS, Jones AL, Hradek GT, Huling S. Hepatocyte handling of immunoglobulin A in the rat: the role of microtubules. Gastroenterology 85: 130-140, 1983.
27. Gong AY, Zhou R, Hu G, Li X, Splinter PL, O'Hara SP, LaRusso NF, Soukup GA, Dong H, Chen XM. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol 182: 1325-1333, 2009.
28. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouliere A. Hepatic fibrosis and cirrhosis: the (myo-)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 38: 135-151, 2006.
29. Haller O, Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3: 710-717, 2002.
30. Harada K, Chiba M, Okamura A, Hsu M, Sato Y, Igarashi S, Ren XS, Ikeda H, Ohta H, Kasashima S, Kawashima A, Nakanuma Y. Monocyte chemoattractant protein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis. J Clin Pathol 64: 660-665, 2011.
31. Harada K, Isse K, Nakanuma Y. Interferon gamma accelerates NFkappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 59: 184-190, 2006.
32. Harada K, Isse K, Sato Y, Ozaki S, Nakanuma Y. Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M. Liver Int 26: 935-942, 2006.
33. Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A, Nakanuma Y. Peptide antibiotic human beta-defensin-1 and-2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40: 925-932, 2004.
34. Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest 83: 1657-1667, 2003.
35. Harada K, Ozaki S, Kono N, Tsuneyama K, Katayanagi K, Hiramatsu K, Nakanuma Y. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J Pathol 193: 218-223, 2001.
36. Harada K, Sato Y, Isse K, Ikeda H, Nakanuma Y. Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia. Liver Int 28: 614-621, 2008.
37. Harada K, Sato Y, Itatsu K, Isse K, Ikeda H, Yasoshima M, Zen Y, Matsui A, Nakanuma Y. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia. Hepatology 46: 1146-1154, 2007.
38. Harada K, Shimoda S, Ikeda H, Chiba M, Hsu M, Sato Y, Kobayashi M, Ren XS, Ohta H, Kasashima S, Kawashima A, Nakanuma Y. Significance of periductal Langerhans cells and biliary epithelial cellderived macrophage inflammatory protein-3alpha in the pathogenesis of primary biliary cirrhosis. Liver Int 31: 245-253, 2011.
39. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 157: 261-270, 2009.
40. Harmatz PR, Kleinman RE, Bunnell BW, Bloch KJ, Walker WA. Hepatobiliary clearance of IgA immune complexes formed in the circulation. Hepatology 2: 328-333, 1982.
41. Hazlett L, Wu M. Defensins in innate immunity. Cell Tissue Res 343: 175-188, 2011.
42. Hernandez MG, Shen L, Rock KL. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help. J Immunol 178: 2844-2852, 2007.
43. Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, Kaneko S, Kobayashi K, Nakanuma Y. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 33: 9-18, 2000.
44. Hsu HY, Chang MH, Ni YH, Huang SF. Cytomegalovirus infection and proinflammatory cytokine activation modulate the surface immune determinant expression and immunogenicity of cultured murine extrahepatic bile duct epithelial cells. Clin Exp Immunol 126: 84-91, 2001.
45. Hu W, Blazar BR, Manivel JC, Paradis K, Sharp HL. Phenotypical and functional characterization of intrahepatic bile duct cells from common duct ligated mice. J Lab Clin Med 128: 536-544, 1996.
46. Huang YH, Chou MH, Du YY, Huang CC, Wu CL, Chen CL, Chuang JH. Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest 87: 66-74, 2007.
47. Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Zen Y, Kazumori H, Nakanuma Y. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest 87: 559-571, 2007.
48. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530, 1997.
49. Isse K, Harada K, Nakanuma Y. IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules. Liver Int 27: 672-680, 2007.
50. Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41: 506-516, 2005.
51. Jafri M, Donnelly B, Bondoc A, Allen S, Tiao G. Cholangiocyte secretion of chemokines in experimental biliary atresia. J Pediatr Surg 44: 500-507, 2009.
52. Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 280: 22986-22992, 2005.
53. Jiang GX, Zhong XY, Cui YF, Liu W, Tai S, Wang ZD, Shi YG, Zhao SY, Li CL. IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro. Mol Biol Rep 37: 3813-3818, 2010.
54. Johnson LR, Byrne JH. Essential Medical Physiology. San Diego, CA: Academic, 2003.
55. Jones AL, Huling S, Hradek GT, Gaines HS, Christiansen WD, Underdown BJ. Uptake and intracellular disposition of IgA by rat hepatocytes in monoalyer culture. Hepatology 2: 769-776, 1982.
56. Kamihira T, Shimoda S, Nakamura M, Yokoyama T, Takii Y, Kawano A, Handa M, Ishibashi H, Gershwin ME, Harada M. Biliary epithelial cells regulate autoreactive T cells: implications for biliaryspecific diseases. Hepatology 41: 151-159, 2005.
57. Karrar A, Broome U, Sodergren T, Jaksch M, Bergquist A, Bjornstedt M, Sumitran-Holgersson S. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis. Gastroenterology 132: 1504-1514, 2007.
58. Kimura Y, Leung PS, Kenny TP, Van De Water J, Nishioka M, Giraud AS, Neuberger J, Benson G, Kaul R, Ansari AA, Coppel RL, Gershwin ME. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis. Hepatology 36: 1227-1235, 2002.
59. Korner T, Kropf J, Hackler R, Brenzel A, Gressner AM. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases. Hepatology 23: 423-428, 1996.
60. Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol 290: G765-G771, 2006.
61. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718, 1995.
62. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 429: 119-129, 1996.
63. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240, 2005.
64. Leifeld L, Ramakers J, Schneiders AM, Dumoulin FL, Sterneck M, Muller A, Sauerbruch T, Spengler U. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J Pathol 194: 478-483, 2001.
65. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 112: 968-977, 1997.
66. Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology 24: 561-567, 1996.
67. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 22: 591-595, 1995.
68. Li Z, Dranoff JA, Chan EP, Uemura M, Sevigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 46: 1246-1256, 2007.
69. Lohr M, Scherer R, Schneider HT, May A, Hahn EG, Zirngibl H, Kloppel G, Ell C. Extracellular matrix proteins in human bile and gallstones. Eur J Gastroenterol Hepatol 7: 135-140, 1995.
70. Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, Sun JZ, Stockard CR, Frost AR, Chen YF, Grizzle WE, Fallon MB. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 129: 682-695, 2005.
71. Markus BH, Duquesnoy RJ, Blaheta RA, Scholz M, Encke A. Role of HLA antigens in liver transplantation with special reference to cellular immune reactions. Langenbecks Arch Surg 383: 87-94, 1998.
72. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, Romanelli RG, Laffi G, Gentilini P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 152: 423-430, 1998.
73. Martins EB, Chapman RW, Marron K, Fleming KA. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases. J Clin Pathol 49: 53-56, 1996.
74. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 20: 376-382, 1994.
75. Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69: 1339-1343, 1995.
76. Miglio F, Pignatelli M, Mazzeo V, Baraldini M, Stefanini GF, Guardigli G, Bandini G, Ricci P, Tura S, Gasbarrini G. Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation. J Hepatol 5: 182-189, 1987.
77. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139: 1221-1229, 1991.
78. Miyaso H, Morimoto Y, Ozaki M, Haga S, Shinoura S, Choda Y, Iwagaki H, Tanaka N. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gutderived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol 20: 1859-1866, 2005.
79. Morita M, Watanabe Y, Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19: 426-431, 1994.
80. Morland CM, Fear J, McNab G, Joplin R, Adams DH. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc Assoc Am Physicians 109: 372-382, 1997.
81. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 12: 63-84, 1994.
82. Nakamura M, Funami K, Komori A, Yokoyama T, Aiba Y, Araki A, Takii Y, Ito M, Matsuyama M, Koyabu M, Migita K, Taniguchi K, Fujioka H, Yatsuhashi H, Matsumoto M, Ishibashi H, Seya T. Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers. Hepatol Int 2: 222-230, 2008.
83. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 38: 1072-1076, 2000.
84. Nozaki I, Lunz JG, 3rd Specht S, Park JI, Giraud AS, Murase N, Demetris AJ. Regulation and function of trefoil factor family 3 expression in the biliary tree. Am J Pathol 165: 1907-1920, 2004.
85. Nozaki I, Lunz JG, 3rd Specht S, Stolz DB, Taguchi K, Subbotin VM, Murase N, Demetris AJ. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 85: 109-123, 2005.
86. O'Hara SP, Bogert PS, Trussoni CE, Chen X, LaRusso NF. TLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis. J Parasitol 97: 813-821, 2011.
87. O'Hara SP, Small AJ, Gajdos GB, Badley AD, Chen XM, Larusso NF. HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J Infect Dis 199: 1195-1204, 2009.
88. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276: 10229-10233, 2001.
89. Osnes T, Sandstad O, Skar V, Osnes M. Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis. Digestion 58: 437-443, 1997.
90. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070, 2004.
91. Peppard JV, Orlans E, Andrew E, Payne AW. Elimination into bile of circulating antigen by endogenous IgA antibody in rats. Immunology 45: 467-472, 1982.
92. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest 84: 153-159, 2004.
93. Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B, Lewindon PJ. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 49: 533-544, 2009.
94. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology 30: 351-357, 1999.
95. Robbins SL, Kumar V, Cotran RS. Robbins and Cotran Pathologic Basis of Disease. Philadelphia, PA: Saunders Elsevier, 2010.
96. Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans 25: 466-470, 1997.
97. Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 13: 239-246, 1991.
98. Sakisaka S, Gondo K, Yoshitake M, Harada M, Sata M, Kobayashi K, Tanikawa K. Functional differences between hepatocytes and biliary epithelial cells in handling polymeric immunoglobulin A2 in humans, rats, and guinea pigs. Hepatology 24: 398-406, 1996.
99. Sasaki M, Tsuneyama K, Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 83: 1403-1413, 2003.
100. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer J, Poustka A, Nakanuma Y. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 24: 29-37, 2004.
101. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 29: 409-416, 1998
102. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177: 1272-1281, 2006.
103. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483, 1998.
104. Scholz M, Cinatl J, Blaheta RA, Kornhuber B, Markus BH, Doerr HW. Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection. Tissue Antigens 49: 640-643, 1997.
105. Sheen-Chen S, Chen W, Eng H, Sheen C, Chou F, Cheng Y, Lee T. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 28: 298-301, 2000.
106. Spengler U, Leifeld L, Braunschweiger I, Dumoulin FL, Lechmann M, Sauerbruch T. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 26: 31-36, 1997
107. Srivatsa G, Giraud AS, Ulaganathan M, Yeomans ND, Dow C, Nicoll AJ. Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology 40: 261-268, 2002.
108. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286, 2007.
109. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 37: 689-696, 1992.
110. Terada R, Yamamoto K, Hakoda T, Shimada N, Okano N, Baba N, Ninomiya Y, Gershwin ME, Shiratori Y. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 83: 665-672, 2003.
111. Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci 53: 888-903, 1997.
112. Tomana M, Kulhavy R, Mestecky J. Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94: 762-770, 1988.
113. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, De Lellis R, Coppel R, Ansari A, Gershwin ME. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 21: 1031-1037, 1995.
114. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 270: 169-184, 2002.
115. Vierling JM. Immunologic mechanisms of hepatic allograft rejection. Semin Liver Dis 12: 16-27, 1992.
116. Wang AP, Migita K, Ito M, Takii Y, Daikoku M, Yokoyama T, Komori A, Nakamura M, Yatsuhashi H, Ishibashi H. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 25: 85-91, 2005.
117. Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev 206: 64-82, 2005.
118. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 78: 89-100, 1998.
119. Yokomuro S, Lunz JG, 3rd Sakamoto T, Ezure T, Murase N, Demetris AJ. The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro. Cytokine 12: 727-730, 2000.
120. Yokomuro S, Tsuji H, Lunz JG, 3rd Sakamoto T, Ezure T, Murase N, Demetris AJ. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32: 26-35, 2000.
121. Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S, Mori T, Fujiwara S, Koyabu M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Ishibashi H. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and-MAPK signaling pathways. Liver Int 26: 467-476, 2006.
122. Yu J, Lavoie EG, Sheung N, Tremblay JJ, Sevigny J, Dranoff JA. IL-6 downregulates transcription of NTPDase2 via specific promoter elements. Am J Physiol Gastrointest Liver Physiol 294: G748-G756, 2008